Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
Bangkun Yang, Jichun Zhang, Mei Han, et al.
Psychopharmacology (2016) Vol. 233, Iss. 19-20, pp. 3647-3657
Open Access | Times Cited: 89

Showing 26-50 of 89 citing articles:

Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants
Yating Wang, Ningning Zhang, Lingjie Liu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 594, pp. 46-56
Closed Access | Times Cited: 30
Ketamine’s rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors
Anastasiya Zaytseva, Evelina Bouckova, McKennon J Wiles, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 18
Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms
Brendan Hare, Sriparna Ghosal, Ronald S. Duman
Chronic Stress (2017) Vol. 1
Open Access | Times Cited: 61
Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling
Min Ma, Qian Ren, Chun Yang, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 57
Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation
Zhaoxiang Ren, Pengju Yan, Liu-shuai Zhu, et al.
Psychopharmacology (2017) Vol. 235, Iss. 1, pp. 233-244
Closed Access | Times Cited: 57
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
Filippo Caraci, Francesca Calabrese, Raffaella Molteni, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 3, pp. 475-504
Open Access | Times Cited: 57
Dammarane sapogenins alleviates depression-like behaviours induced by chronic social defeat stress in mice through the promotion of the BDNF signalling pathway and neurogenesis in the hippocampus
Ning Jiang, Jingwei Lv, Haixia Wang, et al.
Brain Research Bulletin (2019) Vol. 153, pp. 239-249
Closed Access | Times Cited: 49
Prefrontal cortical trkB, glucocorticoids, and their interactions in stress and developmental contexts
Elizabeth T. Barfield, Shannon L. Gourley
Neuroscience & Biobehavioral Reviews (2018) Vol. 95, pp. 535-558
Open Access | Times Cited: 47
Bidirectional Dysregulation of AMPA Receptor-Mediated Synaptic Transmission and Plasticity in Brain Disorders
Hongyu Zhang, Clive R. Bramham
Frontiers in Synaptic Neuroscience (2020) Vol. 12
Open Access | Times Cited: 40
Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review
Johanna Louise Keeler, Janet Treasure, Mário F. Juruena, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 4158-4158
Open Access | Times Cited: 39
Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers
Ellen Scotton, Bárbara Antqueviezc, Mailton Vasconcelos, et al.
Biochemical Pharmacology (2022) Vol. 198, pp. 114963-114963
Closed Access | Times Cited: 25
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Courtney M. Vecera, Alan C. Courtes, Gregory Jones, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1572-1572
Open Access | Times Cited: 14
5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
Kai Zhang, Chao Dong, Yūkō Fujita, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 21, Iss. 2, pp. 157-163
Open Access | Times Cited: 47
Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects
John E. Donello, Pradeep Banerjee, Yong‐Xin Li, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 3, pp. 247-259
Open Access | Times Cited: 41
Oxytocin prevents the increase of cocaine-related responses produced by social defeat
Carmen Ferrer‐Pérez, Adriana Castro‐Zavala, Miguel Á. Luján, et al.
Neuropharmacology (2018) Vol. 146, pp. 50-64
Open Access | Times Cited: 40
TrkB neurotrophin receptor at the core of antidepressant effects, but how?
Tomi Rantamäki
Cell and Tissue Research (2019) Vol. 377, Iss. 1, pp. 115-124
Open Access | Times Cited: 39
Antidepressant‐like effects of 20(S)‐protopanaxadiol in a mouse model of chronic social defeat stress and the related mechanisms
Ning Jiang, Jing‐wei Lv, Haixia Wang, et al.
Phytotherapy Research (2019) Vol. 33, Iss. 10, pp. 2726-2736
Closed Access | Times Cited: 36
Brain region–specific roles of brain-derived neurotrophic factor in social stress–induced depressive-like behavior
Man Yong Han, Deyang Zeng, Wei Tan, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 159-173
Open Access | Times Cited: 4
AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders
Daniel Choquet, Patricio Opazo, Hongyu Zhang
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
Unraveling the brain expression of BDNF in a mouse model of Anorexia Nervosa
Nicolás Ramoz, Jingxian Cao, Nicolas Lebrun, et al.
Research Square (Research Square) (2025)
Closed Access
Beyond Ketamine: New Approaches to the Development of Safer Antidepressants
Shigeyuki Chaki
Current Neuropharmacology (2017) Vol. 15, Iss. 7
Open Access | Times Cited: 38
A potential role for microglia in stress- and drug-induced plasticity in the nucleus accumbens: A mechanism for stress-induced vulnerability to substance use disorder
Anna G. McGrath, Lisa A. Briand
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 360-369
Open Access | Times Cited: 34
Striatal Shati/Nat8l–BDNF pathways determine the sensitivity to social defeat stress in mice through epigenetic regulation
Hajime Miyanishi, Shin‐ichi Muramatsu, Atsumi Nitta
Neuropsychopharmacology (2021) Vol. 46, Iss. 9, pp. 1594-1605
Open Access | Times Cited: 25
Antidepressants in the post-ketamine Era: Pharmacological approaches targeting the glutamatergic system
Shigeyuki Chaki, Mai Watanabe
Neuropharmacology (2022) Vol. 223, pp. 109348-109348
Closed Access | Times Cited: 16
Investigational drugs for treating major depressive disorder
Ashish Dhir
Expert Opinion on Investigational Drugs (2016) Vol. 26, Iss. 1, pp. 9-24
Closed Access | Times Cited: 29

Scroll to top